These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1440607)

  • 1. Inhibition of acute TCDD toxicity by treatment with anti-tumor necrosis factor antibody or dexamethasone.
    Taylor MJ; Lucier GW; Mahler JF; Thompson M; Lockhart AC; Clark GC
    Toxicol Appl Pharmacol; 1992 Nov; 117(1):126-32. PubMed ID: 1440607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of anti-TNF-alpha antibody and dexamethasone on TCDD-induced oxidative stress in mice.
    Alsharif NZ; Hassoun E; Bagchi M; Lawson T; Stohs SJ
    Pharmacology; 1994 Feb; 48(2):127-36. PubMed ID: 8134404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute inflammatory response to sheep red blood cells in mice treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin: the role of proinflammatory cytokines, IL-1 and TNF.
    Moos AB; Baecher-Steppan L; Kerkvliet NI
    Toxicol Appl Pharmacol; 1994 Aug; 127(2):331-5. PubMed ID: 8048078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of c-Src and c-Fos knockout mice for the studies on the role of c-Src kinase signaling in the expression of toxicity of TCDD.
    Enan E; Dunlap DY; Matsumura F
    J Biochem Mol Toxicol; 1998; 12(5):263-74. PubMed ID: 9664232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response relationships of tissue distribution and induction of CYP1A1 and CYP1A2 enzymatic activities following acute exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice.
    Diliberto JJ; Akubue PI; Luebke RW; Birnbaum LS
    Toxicol Appl Pharmacol; 1995 Feb; 130(2):197-208. PubMed ID: 7871533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biphasic response for hepatic microsomal enzyme induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J and DBA/2J mice.
    Shen ES; Guengerich FP; Olson JR
    Biochem Pharmacol; 1989 Nov; 38(22):4075-84. PubMed ID: 2512931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of tumor necrosis factor activity fails to restore 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced suppression of the antibody response to sheep red blood cells.
    Moos AB; Kerkvliet NI
    Toxicol Lett; 1995 Nov; 81(2-3):175-81. PubMed ID: 8553372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2,3,7,8-Tetrachlorodibenzo-p-dioxin induction of cytochrome P450-dependent arachidonic acid metabolism in mouse liver microsomes: evidence for species-specific differences in responses.
    Lee CA; Lawrence BP; Kerkvliet NI; Rifkind AB
    Toxicol Appl Pharmacol; 1998 Nov; 153(1):1-11. PubMed ID: 9875294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and corticosteroid on in vitro lymphocyte maturation.
    Luster MI; Germolec DR; Clark G; Wiegand G; Rosenthal GJ
    J Immunol; 1988 Feb; 140(3):928-35. PubMed ID: 3257509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor involvement in the toxicity of TCDD: the role of endotoxin in the response.
    Clark GC; Taylor MJ
    Exp Clin Immunogenet; 1994; 11(2-3):136-41. PubMed ID: 7826662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanism of action of alpha-naphthoflavone as an inhibitor of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced CYP1A1 gene expression.
    Merchant M; Arellano L; Safe S
    Arch Biochem Biophys; 1990 Aug; 281(1):84-9. PubMed ID: 2166479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue distribution after a single subcutaneous administration of 2,3,7,8-tetrabromodibenzo-p-dioxin in comparison with toxicokinetics of 2,3,7,8-tetrachlorodibenzo-p-dioxin in female Wistar rats.
    Nagao T; Yamashita K; Golor G; Bittmann H; Körner W; Hagenmaier H; Neubert D
    Life Sci; 1996; 58(4):325-36. PubMed ID: 8538369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic vitamin a depletion is a sensitive marker of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure in four rodent species.
    Fletcher N; Hanberg A; Håkansson H
    Toxicol Sci; 2001 Jul; 62(1):166-75. PubMed ID: 11399804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. alpha-Naphthoflavone antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced murine lymphocyte ethoxyresorufin-O-deethylase activity and immunosuppression.
    Blank JA; Tucker AN; Sweatlock J; Gasiewicz TA; Luster MI
    Mol Pharmacol; 1987 Jul; 32(1):169-72. PubMed ID: 3037301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2,3,7,8-Tetrachlorodibenzo-p-dioxin as growth modulator in mouse hepatocytes with high and low affinity Ah receptor.
    Schrenk D; Schäfer S; Bock KW
    Carcinogenesis; 1994 Jan; 15(1):27-31. PubMed ID: 8293544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of vitamin A and vitamin E succinate against 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced body wasting, hepatomegaly, thymic atrophy, production of reactive oxygen species and DNA damage in C57BL/6J mice.
    Alsharif NZ; Hassoun EA
    Basic Clin Pharmacol Toxicol; 2004 Sep; 95(3):131-8. PubMed ID: 15447737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated hepatotoxicity in C57BL/6J and DBA/2J mice.
    Shen ES; Gutman SI; Olson JR
    J Toxicol Environ Health; 1991 Apr; 32(4):367-81. PubMed ID: 2016751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on TNF-alpha levels in the skin of congenic haired and hairless mice.
    Connor MJ; Nanthur J; Puhvel SM
    Toxicol Appl Pharmacol; 1994 Nov; 129(1):12-5. PubMed ID: 7974484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyp1a1(-/-) male mice: protection against high-dose TCDD-induced lethality and wasting syndrome, and resistance to intrahepatocyte lipid accumulation and uroporphyria.
    Uno S; Dalton TP; Sinclair PR; Gorman N; Wang B; Smith AG; Miller ML; Shertzer HG; Nebert DW
    Toxicol Appl Pharmacol; 2004 May; 196(3):410-21. PubMed ID: 15094312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.